Blog

Jan 15, 2025, 13:07

Yan Leyfman: Using routine blood tests to predict immunotherapy response across multiple cancers

Yan Leyfman shared on LinkedIn:

“Honored to contribute to this groundbreaking work with the incredible Drs. Fitzgerald, Diego Chowell, and Thomas Marron.

Memorial Sloan Kettering Cancer Center and Icahn School of Medicine at Mount Sinai unveil SCORPIO — an innovative AI tool using routine blood tests to predict immunotherapy response across multiple cancers. Changing the game in cancer care! ”

Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical data | Nature Medicine

Authors: Seong-Keun Yoo, Conall W. Fitzgerald, Byuri Angela Cho, Bailey G. Fitzgerald, Catherine Han, Elizabeth S. Koh, Abhinav Pandey, Hannah Sfreddo, Fionnuala Crowley, Michelle Rudshteyn Korostin, Neha Debnath, Yan Leyfman, Cristina Valero, Mark Lee, Joris L. Vos, Andrew Sangho Lee, Karena Zhao, Stanley Lam, Ezekiel Olumuyide, Fengshen Kuo, Eric A. Wilson, Pauline Hamon, Clotilde Hennequin, Miriam Saffern, Lynda Vuong, A. Ari Hakimi, Brian Brown, Miriam Merad, Sacha Gnjatic, Nina Bhardwaj, Matthew D. Galsky, Eric E. Schadt, Robert M. Samstein, Thomas U. Marron, Mithat Gönen, Luc G. T. Morris.

Yan Leyfman: Using routine blood tests to predict immunotherapy response across multiple cancers

A. Ari Hakimi Abhinav Pandey Andrew Sangho Lee Bailey G. Fitzgerald Brian Brown Byuri Angela Cho cancer Catherine Han Clotilde Hennequin Conall W. Fitzgerald Cristina Valero Diego Chowell Elizabeth S. Koh Eric A. Wilson Eric E. Schadt Ezekiel Olumuyide Fengshen Kuo Fionnuala Crowley Hannah Sfreddo Joris L. Vos Karena Zhao Luc G.T. Morris Lynda Vuong Mark Lee Matthew D. Galsky Memorial Sloan Kettering Cancer Center Michelle Rudshteyn Korostin Miriam Merad Miriam Saffern Mithat Gönen Neha Debnath Nina Bhardwaj OncoDaily Oncology Pauline Hamon Robert M. Samstein Sacha Gnjatic Seong-Keun Yoo Stanley Lam Thomas Marron Thomas U. Marron Yan Leyfman

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage